(Press-News.org) Reston, VA (January 13, 2026)--A newly developed radiopharmaceutical pair can precisely detect and effectively treat--completely eradicating tumors in certain preclinical models--gastric and pancreatic tumors. Targeting the well-defined and accessible biomarker claudin-18.2, the theranostic technique has the potential to move the field substantially closer to durable disease control and potentially cure--in otherwise difficult-to-treat solid tumors. This research was published in the January issue of The Journal of Nuclear Medicine.
Advanced upper gastrointestinal cancers, including esophageal, gastric, and pancreatic cancer, are among the deadliest cancers worldwide, accounting for one-third of all cancer deaths. Patients have very limited treatment options, especially in advanced stages, and current therapies provide only modest improvements in survival. As such, there is a critical unmet need for more effective and more precise approaches.
"Claudin-18.2 recently gained clinical attention following U.S. Food and Drug Administration approval of the gastric cancer treatment zolbetuximab, which targets the biomarker," said Shadi Esfahani, MD, MPH, nuclear medicine physician at Massachusetts General Hospital in Boston. "To further explore the utility of claudin-18.2, my colleagues and I developed a first-in-class claudin-18.2-targeted PET radiopharmaceutical and a therapeutic counterpart to identify and treat gastric and pancreatic tumors."
To evaluate the theranostic pair, preclinical murine models were developed with both pancreatic and gastric cancer cell lines. Serial PET imaging with 89Zr-DFO-zolbetuximab or 89Zr-DFO-IgG as a control was performed at one, three, and six days, followed by ex vivo analysis of biodistribution. Next, tumor-bearing mice received a single intravenous injection 177Lu-DOTA-zolbetuximab (high or low dose), non-radiolabeled zolbetuximab, 177Lu-DOTA-IgG, 177Lu-DOTA, or saline as a treatment. Effectiveness and toxicity of the treatments were evaluated by laboratory and histologic analyses.
Serial PET imaging demonstrated a high tumor uptake of 89Zr-DFO-zolbetuximab at all timepoints--significantly higher than the uptake seen in mice imaged with control 89Zr-DFO-IgG. High-dose 177Lu-DOTA-zolbetuximab resulted in reduced tumor growth in gastric and pancreatic mice models, with complete regression of most pancreatic tumors. No radiation-induced toxicities were observed during the study.
"Claudin 18.2 based theranostics could meaningfully change patient care in two important ways," noted Esfahani. "First, claudin 18.2 targeted PET imaging enables noninvasive identification of patients whose tumors strongly express this target. Second, claudin 18.2 targeted radiopharmaceutical therapy has the potential to deliver highly focused radiation directly to tumor cells, leading to significant tumor shrinkage and the possibility of improved survival."
She continued, "More broadly, the study underscores how advances in biomarker discovery, radiopharmaceutical development, and patient selection are bringing the field closer to treatments with curative potential rather than incremental benefit. As additional tumor-specific targets are identified and validated, molecular imaging-guided theranostics could increasingly enable personalized, highly effective, and safer cancer treatments, positioning nuclear medicine at the forefront of next-generation oncology."
The authors of "Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors" include Shvan J. Raheem, Santosh Bashyal, Arvin Haj-Mirzaian, Youself Khazaei Monfared, Umar Mahmood, Pedram Heidari, and Shadi A. Esfahani, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Matthew R. Strickland, David T. Ting, and Samuel J. Klempner, Division of Hematology Oncology, Mass General Brigham Cancer Institute, and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Benjamin M. Larimer, Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics--precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
Novel theranostic model shows curative potential for gastric and pancreatic tumors
2026-01-15
ELSE PRESS RELEASES FROM THIS DATE:
How beige fat keeps blood pressure in check
2026-01-15
Obesity causes hypertension. Hypertension causes cardiovascular disease. And cardiovascular disease is the leading cause of death worldwide. While the link between fat and high blood pressure is clearly central to this deadly chain, its biological basis long remained unclear. What is it about fat that impacts vascular function and blood pressure control?
Now, a new study demonstrates how thermogenic beige fat—a type of adipose tissue, distinct from white fat, that helps the body burn energy—directly shapes blood pressure control. Building on clinical evidence ...
Fossils reveal ‘latitudinal traps’ that increased extinction risk for marine species
2026-01-15
A new study led by researchers at the University of Oxford has shown that the shape and orientation of coastlines significantly influenced extinction patterns for animals living in the shallow oceans during the last 540 million years. In particular, animals living on convoluted or east-west orientated coastlines (such as those found in the Mediterranean and Gulf of Mexico today) were more likely to go extinct than those living on north-south orientated coastlines.
The findings, published today (15 Jan) in Science, provide new insight towards understanding patterns of biodiversity distribution throughout ...
Review: The opportunities and risks of AI in mental health research and care
2026-01-15
In a Review, Nils Opel and Michael Breakspear discuss how artificial intelligence (AI) can be responsibly and effectively integrated into mental health care, given the unique clinical, ethical, and societal challenges of the field. “It is tempting to be blinded or bewildered by the technological appeal of AI and its superhuman accomplishments,” write the authors. “We suggest that the opportunities and contradictions of AI can be reconciled by avoiding this technology-centric allure and instead adopting a human-centered approach…” AI is poised to reshape mental health care. Recent advances in machine ...
New map reveals features of Antarctic’s ice-covered landscape
2026-01-15
Using satellite data and the physics of ice flow, researchers have mapped Antarctica’s hidden subglacial bedrock landscape – one of the Solar System’s least mapped planetary surfaces – in unprecedented detail, revealing previously unseen geological structures shaping the ice sheet from below. The findings not only improve ice sheet models but can also guide future geophysical surveys and reduce uncertainty in projections of ice loss and sea-level rise. Hidden beneath Antarctica’s massive ice sheet lies a complex landscape of mountains, valleys, plains, ...
Beige fat promotes healthy vascular function and blood pressure in mice
2026-01-15
Beige fat surrounding blood vessels actively works to keep high blood pressure in check, according to a new study in mice, promoting healthy vascular function even during obesity. The findings support the notion that therapeutic activation of thermogenic fat tissue could help reduce the risk of cardiovascular disease. High blood pressure is a leading cause of heart disease and stroke and is a major risk factor for early death. Adipose tissue, or fat, plays an active role in regulating blood pressure. However, growing evidence suggests that it’s ...
Chronic low-dose pesticide exposure reduces the life span of wild lake fish, China-based study shows
2026-01-15
Even at amounts considered safe under regulatory frameworks, chronic exposure to the pesticide chlorpyrifos accelerates physiological aging and shortens the life spans of wild fish, according to a new study based in China. The findings raise concerns about the long-term impacts of low-level environmental pesticide contamination. Traditionally, to define risk, chemical safety regulations have relied on the acute dangers of short-term exposure to high doses. While this method captures immediate toxicity, it assumes that exposure to much lower concentrations is more ...
Tiny earthquakes reveal hidden faults under Northern California
2026-01-15
By tracking swarms of very small earthquakes, seismologists are getting a new picture of the complex region where the San Andreas fault meets the Cascadia subduction zone, an area that could give rise to devastating major earthquakes. The work, by researchers at the U.S. Geological Survey, the University of California, Davis and the University of Colorado Boulder, is published Jan. 15 in Science.
“If we don’t understand the underlying tectonic processes, it’s hard to predict the seismic hazard,” said coauthor Amanda Thomas, professor of earth and planetary sciences at UC Davis.
Three of the great tectonic ...
Long-term pesticide exposure accelerates aging and shortens lifespan in fish
2026-01-15
EMBARGOED: May be published no earlier than 2 p.m. ET on Thursday, Jan. 15.
Long-term exposure to low levels of a common agricultural pesticide can accelerate physiological aging and shorten lifespan in fish — a finding from new research led by University of Notre Dame biologist Jason Rohr with potentially far-reaching implications for environmental regulations and human health.
The study, published in Science, shows that chronic exposure to the insecticide chlorpyrifos at concentrations ...
Professor Tae-Woo Lee's research group develops groundbreaking perovskite display technology demonstrating the highest efficiency and industry-level operational lifetime
2026-01-15
A domestic research team led by Professor Tae-Woo Lee (Department of Materials Science and Engineering, Seoul National University, Republic of Korea & SN Display Co., Ltd) has developed a hierarchical-shell perovskite nanocrystal technology that simultaneously overcomes the long-standing instability of metal-halide perovskite emitters while achieving record-breaking quantum yield, operational stability, and scalability. This breakthrough paves the way for next-generation vivid-color display technologies. The results were published in the world’s leading academic journal ...
The “broker” family helps tidy up the cell
2026-01-15
FRANKFURT. Maintaining cellular order is a major logistical challenge: Individual mammalian cells contain billions of protein molecules, which must be synthesized, deployed, and removed with precision. In the ubiquitin-proteasome system (UPS), proteins destined for degradation are tagged with chains of several ubiquitin proteins and then degraded by the proteasome. The crucial step is the target selection: E3 ligases are enzymes that act as molecular “broker” by binding specific target proteins and coordinating the transfer of ubiquitin from ...